Covid-19 Live News: Bharat Biotech Submits Covaxin's Phase-3 Trial Data To DCGI | Breaking News

Covid-19 Live News: Bharat Biotech Submits Covaxin's Phase-3 Trial Data To DCGI | Breaking NewsПодробнее

Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under ReviewПодробнее

Covid-19 Vaccine: Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets TodayПодробнее

SEC Gives Approval Of Covaxin's Phase 3 Trial Data; 77.6% Efficacy Seen: Sources | Republic TVПодробнее

Covaxin Phase 3 Trial Data: DCGI’s Expert Panel Says Bharat Biotech’s Vaccine 77.8% EffectiveПодробнее

Covaxin for kids: Bharat Biotech completes phase 2/3 trials, to submit data to DCGI next weekПодробнее

Covaxin 77.8% Effective In Phase 3 Trial Data: SourcesПодробнее

Bharat Biotech Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacyПодробнее

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia NewsПодробнее

WHO's Pre-Qualification Meet On Bharat Biotech's Covaxin Data Tomorrow | Breaking NewsПодробнее

Bharat Biotech's Covaxin Shows 81% Efficacy In Phase 3 Trials Conducted On 25k SubjectsПодробнее

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | CovidПодробнее

Bharat Biotech set for phase-3 trials of COVAXINПодробнее

BHARAT BIOTECH GETS NOD FROM DCGI PANEL FOR PHASE III TRIALSПодробнее

Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% EfficacyПодробнее

Covaxin: Phase 3 Trial data shared with expert panelПодробнее

COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By DCGIПодробнее

Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%| BreakingПодробнее

Bharat Biotech seeks DCGI nod for phase-3 trials of intranasal COVID vaccine as booster doseПодробнее

Phase III Trials Of Bharat Biotech's Covaxin | CNBC-TV18Подробнее